Metabolomics in hepatocellular carcinoma: From biomarker discovery to precision medicine

Hepatocellular carcinoma (HCC) remains a global health burden, and is mostly diagnosed at late and advanced stages. Currently, limited and insensitive diagnostic modalities continue to be the bottleneck of effective and tailored therapy for HCC patients. Moreover, the complex reprogramming of metabo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xingyun, Wang, Zihao, Luo, Li, Shu, Dan, Wang, Kui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medical Technology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845953/
https://www.ncbi.nlm.nih.gov/pubmed/36688143
http://dx.doi.org/10.3389/fmedt.2022.1065506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845953/
https://www.ncbi.nlm.nih.gov/pubmed/36688143
http://dx.doi.org/10.3389/fmedt.2022.1065506

Ejemplares similares